Saturday, June 29, 2013

Eat To Live | Fast and Sustained Weight Loss | Healthy, Nutritous Diet that Prevents and Reverses Disease | DrFuhrman.com

Eat To Live | Fast and Sustained Weight Loss | Healthy, Nutritous Diet that Prevents and Reverses Disease | DrFuhrman.com

Monday, June 3, 2013

Canagliflozin: “new class” of diabetes drug approved in the U.S., and under review in Canada

Canagliflozin -- the once-a-day oral pill  -- belongs to a “new class” of diabetes medication has been approved by the U.S. Food and Drug Administration (FDA) on March 29, 2013. The drug's mode of action is in the kidneys to inhibit sodium-glucose cotransporter 2 (SGLT2). 

"After glucose is filtered from the blood into the kidneys, canagliflozin suppresses SGLT2 transporters from carrying the glucose back into the blood. Instead, the glucose is diverted and released into the urine. This effectively pushes excess blood glucose out of the body via the kidneys and urinary tract."

Canagliflozin is currently pending approval by Health Canada.

To download full-text article, Click Here



Source: Published in the Canadian Medical Association Journal (www.cmaj.ca). June 3, 2013.

In the UK, doctors will have to show fitness to practise every five years


"Doctors with a licence to practise in the United Kingdom from the General Medical Council (GMC) are now legally required to undergo revalidation, that is, to provide evidence of ongoing fitness to practise every five years."

To download full-text article Click Here.



Source: Published by the Canadian Medical Association Journal (www.cmaj.ca), May 31, 2013.

Acupuncture: Effective or placebo?


David Colquhoun PhD and Steven Novella MD, wrote an article which concludes that acupuncture is worthless for pain relief. [Colquhoun D, Novella S. Acupuncture is theatrical placebo. Anesthesia & Analgesia 116:1360-1363, 2013] Their report concludes that "the benefits of acupuncture are likely nonexistent, or at best are too small and too transient to be of any clinical significance." Click here for the ink to the article.

For more information, Colquhoun's blog (http://www.dcscience.net/?p=6060) contains links to supportive documents.

[Source: Consumer Health Digest Digest #13-21, May 30, 2013, edited by Stephen Barrett MD]